Search results

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods. 

Wombat used in study that showed tuneable thermal expansion by controlled gas sorption.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Research reveals that strong westerly winds weaken the Southern Ocean’s ability to store carbon and thereby contribute to faster accumulation of carbon dioxide in the atmosphere

Measurement research undertaken to ensure safe, well-engineered nanoparticles

Radiocarbon analyses on corals from two sites in Australian waters of the southwest (SW) Pacific has indicated significant changes in ocean circulation in the Pacific and large climate variability during the early to mid-Holocene period (8,000-5,400 years ago).